Search is Powered by Google
Cancer / Oncology News

Cancer Conference For Arizona's Native Americans Oct. 11

Main Category: Cancer / Oncology
Also Included In: Nutrition / Diet;  Conferences;  Psychology / Psychiatry
Article Date: 02 Oct 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Arizona Myeloma Network, working with other non-profit groups throughout Arizona, is planning its first Fort Defiance Cancer Awareness and Advocacy Conference focusing on the health challenges facing Native Americans.

The free Oct. 11 conference at the Navajo Nation Museum in Window Rock, is being co-sponsored by the John Wayne Cancer Foundation, named for the actor made famous by movies such as Stagecoach and The Searchers, filmed in the Navajo Nation's Monument Valley.

The gathering will include speakers from cancer-care organizations and hospitals, providing information about services, resources and advances in cancer treatments.

The conference was conceived by Mechelle Morgan-Flowers, a nurse and supervisor who works at the nearby Fort Defiance Indian Hospital, on the high desert plateau of northeastern Arizona.

"My professional experience with cancer patients has led me to believe there is a need for increased awareness about cancer in the communities we serve,'' said Morgan-Flowers, who has tended the health needs of the Navajo Nation since 1996.

Morgan-Flowers got the idea in March while attending a cancer awareness program in Scottsdale sponsored by the Arizona Myeloma Network.

Organizers hope the conference will result in increased access to medical resources, improved services and better cancer treatments for the Navajo Nation, which spans parts of Arizona, Utah and New Mexico.

"Not everyone can travel (for hours to larger metro areas) for specialized care,'' said Barbara Kavanagh, founder and chief executive officer of the Arizona Myeloma Network, which helps victims of a form of bone-marrow cancer.

After being contacted by Morgan-Flowers, Kavanagh sought the help of other Arizona organizations, including the Translational Genomics Research Institute (TGen). In 2006, TGen joined with the Multiple Myeloma Research Foundation, the Broad Institute of MIT and Harvard in launching the Multiple Myeloma Genomics Initiative, a multi-million-dollar cutting-edge genome-mapping collaboration designed to combat this deadly cancer with advanced treatments.

Kavanagh connected with Dr. Bodour Salhia, a post-doctorate fellow who is investigating breast cancer and multiple myeloma at TGen's Integrated Cancer Genomics Division.

To see first-hand the problems involved in rural Indian healthcare, Kavanagh and Salhia traveled in July to Fort Defiance to visit with Morgan-Flowers and other health professionals serving the Navajo people.

"We just listened to what people had to say. People are dying, and they are so underserved,'' said Salhia, who has since worked in an advisory role to organize the conference, establish its goals, contact speakers and help set the agenda.

Access to specialized care is among the highest needs among underserved communities like the Navajo Nation. Convenient transportation is unavailable to many. Cancer patients must travel hundreds of miles to larger metro areas like Phoenix, Flagstaff and Albuquerque to receive care and treatment.

Parts of the vast Navajo Nation are among the most rural places in Arizona. During the fall and winter, snow and rain can make its thousands of miles of dirt roads impassible. The 17-million-acre Navajo Nation includes 11.6 million acres in Arizona, or nearly one-sixth of The Grand Canyon State.

Primary agenda items: About the conference

What: Fort Defiance Cancer Awareness and Advocacy Conference.

Where: Navajo Nation Museum, Arizona 264 and Postal Loop Road, Window Rock, Arizona.

When: 8:30 a.m.-5 p.m. Oct. 11.

Who: Open to the public.

Cost: Free.

Why: To help provide Arizona's Native Americans with a higher awareness of cancer and greater access to medical care.

Primary sponsors: Arizona Myeloma Network, Black Bear Diners and the John Wayne Cancer Foundation. Participating organizations: Fort Defiance Indian Hospital, Navajo Nation, Intertribal Council of Arizona, Arizona Advisory Council on Indian Health Care, Southwest American Indian Collaborative Network, Dine′ College, Mayo Clinic, Translational Genomics Research Institute, Scottsdale Healthcare, Virginia G. Piper Cancer Center, St. Joseph's Cancer Center, Arizona Cancer Coalition, Leukemia & Lymphoma Society (Desert Mountain States Chapter), AeroCare Medical Transport, AmeriChoice Insurance Agency/United HealthCare Insurance Co., Arizona State University, University of Arizona, and Northern Arizona University.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Details, or to provide sponsorships or donations: http://www.azmyelomanetwork.org/.

Source: Barbara Kavanagh
The Translational Genomics Research Institute




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...